Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

Concerns over reports of suicidal ideation associated with semaglutide treatment, a
glucagon-like peptide 1 receptor (GLP1R) agonist medication for type 2 diabetes (T2DM) …

An infectious etiology of Alzheimer's disease has been postulated for decades. It remains
unknown whether SARS-CoV-2 viral infection is associated with increased risk for …

The emergence of large-scale phenotypic, genetic, and other multi-model biochemical data
has offered unprecedented opportunities for drug discovery including drug repurposing …

Objective To investigate whether COVID-19 infection was associated with increased risk for
incident respiratory syncytial virus (RSV) infections and associated diseases among young …

The incidence of endocarditis in the US is increasing, driven in part by the rise in
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …

Cannabis is the most frequently used illicit drug in the United States with more than 45
million users of whom one-third suffer from a cannabis use disorder (CUD). Despite its high …

Background and aims Cocaine use disorder (CUD) is a significant public health issue for
which there is no Food and Drug Administration (FDA) approved medication. Drug …

Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …